Candidozyma auris Outbreak and Its Effective Control in a General Hospital
- PMID: 40558169
- PMCID: PMC12189113
- DOI: 10.3390/antibiotics14060579
Candidozyma auris Outbreak and Its Effective Control in a General Hospital
Abstract
Background/Objectives:Candidozyma auris (C. auris) is a multidrug-resistant pathogen recognized as a serious global public health threat. Herein, we report a C. auris outbreak that was successfully contained in a general hospital located in Athens, Greece. Methods: This study was conducted between December 2021 and December 2023. Upon identification of the first imported case of C. auris, the following infection control measures were applied in a stepwise approach: the promotion of hand hygiene, contact precautions and isolation, chlorhexidine gluconate bathing of patients, enhanced environmental cleaning, and active surveillance cultures of all high-risk patients upon admission. Active surveillance cultures were performed weekly in non-colonized ICU patients. Results: A total of 1564 screening samples from 890 patients were analyzed. Sixty-three patients were identified to be colonized and three to be infected with C. auris. After implementing screening and enhanced environmental cleaning, the quarterly incidence of hospital-acquired cases decreased from 0.37 to 0.04 cases per 1000 patient-days (slope of linear trend: -0.08; 95% CI: -0.16 to -0.0004; p = 0.05), despite the continuous inflow of already colonized patients. Conclusions: A bundle of infection control measures, including active surveillance cultures upon admission and enhanced environmental cleaning, can contain C. auris dissemination in acute healthcare settings.
Keywords: C. auris; active surveillance; healthcare-associated infections; infection prevention and control.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures



Similar articles
-
The challenge of preventing and containing outbreaks of multidrug-resistant organisms and Candida auris during the coronavirus disease 2019 pandemic: report of a carbapenem-resistant Acinetobacter baumannii outbreak and a systematic review of the literature.Antimicrob Resist Infect Control. 2022 Jan 21;11(1):12. doi: 10.1186/s13756-022-01052-8. Antimicrob Resist Infect Control. 2022. PMID: 35063032 Free PMC article.
-
Impact of Candida auris on Critically Ill Patients: A Three-Year Observational Study in a Greek Intensive Care Unit.Pathogens. 2025 Mar 28;14(4):328. doi: 10.3390/pathogens14040328. Pathogens. 2025. PMID: 40333088 Free PMC article.
-
Non-pharmacological interventions for preventing delirium in hospitalised non-ICU patients.Cochrane Database Syst Rev. 2021 Jul 19;7(7):CD013307. doi: 10.1002/14651858.CD013307.pub2. Cochrane Database Syst Rev. 2021. PMID: 34280303 Free PMC article.
-
Interventions to improve antibiotic prescribing practices for hospital inpatients.Cochrane Database Syst Rev. 2017 Feb 9;2(2):CD003543. doi: 10.1002/14651858.CD003543.pub4. Cochrane Database Syst Rev. 2017. PMID: 28178770 Free PMC article.
-
Measures implemented in the school setting to contain the COVID-19 pandemic.Cochrane Database Syst Rev. 2022 Jan 17;1(1):CD015029. doi: 10.1002/14651858.CD015029. Cochrane Database Syst Rev. 2022. Update in: Cochrane Database Syst Rev. 2024 May 2;5:CD015029. doi: 10.1002/14651858.CD015029.pub2. PMID: 35037252 Free PMC article. Updated.
References
-
- Suphavilai C., Ko K.K.K., Lim K.M., Tan M.G., Boonsimma P., Chu J.J.K., Goh S.S., Rajandran P., Lee L.C., Tan K.Y., et al. Detection and Characterisation of a Sixth Candida auris Clade in Singapore: A Genomic and Phenotypic Study. Lancet Microbe. 2024;5:100878. doi: 10.1016/S2666-5247(24)00101-0. - DOI - PubMed
LinkOut - more resources
Full Text Sources